1. Home
  2. CTSO vs TGHL Comparison

CTSO vs TGHL Comparison

Compare CTSO & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

SELL

Current Price

$6.01

Market Cap

23.9M

Sector

Health Care

ML Signal

SELL

Logo The GrowHub Limited Class A Ordinary Shares

TGHL

The GrowHub Limited Class A Ordinary Shares

HOLD

Current Price

$0.59

Market Cap

20.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
TGHL
Founded
1997
2020
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
20.4M
IPO Year
2008
2024

Fundamental Metrics

Financial Performance
Metric
CTSO
TGHL
Price
$6.01
$0.59
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $12.25
N/A
AVG Volume (30 Days)
52.9K
★ 77.8K
Earning Date
11-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.79
N/A
EPS
N/A
★ N/A
Revenue
★ $22,503,908.00
N/A
Revenue This Year
$4.91
N/A
Revenue Next Year
$13.58
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 48.53
N/A
52 Week Low
$0.30
$0.27
52 Week High
$7.44
$2.48

Technical Indicators

Market Signals
Indicator
CTSO
TGHL
Relative Strength Index (RSI) 73.08 39.25
Support Level $2.88 $0.56
Resistance Level $7.44 $0.98
Average True Range (ATR) 0.61 0.07
MACD 0.19 -0.02
Stochastic Oscillator 82.52 31.53

Price Performance

Historical Comparison
CTSO
TGHL

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About TGHL The GrowHub Limited Class A Ordinary Shares

The Growhub Ltd operates as the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, the company has developed a multi-faceted approach to address industry challenges. Its business currently comprises two main divisions, which are the Traceability and Authenticity Solutions and Carbon Project Development.

Share on Social Networks: